Le Travenues Technology Limited has informed the Exchange regarding Outcome of Board meeting held on February 13, 2026.
IXIGO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Ixigo met on February 13, 2026 and approved two key items. First, a further investment of approximately €15.3 million (around ₹140 crore) in its wholly-owned Singapore subsidiary IXIGO PTE. LTD., at par value of €1 per share, to fund acquisitions of businesses in Europe. The subsidiary was only incorporated on December 18, 2025, and the investment is targeted to complete by March 31, 2026. Second, the board allotted 112,220 equity shares (face value ₹1 each) to employees who exercised stock options under the ESOS 2016, 2021, and 2024 schemes, generating ₹4.67 lakh for the company. This raised the total paid-up share capital from ₹43.81 crore to ₹43.82 crore, taking the total issued shares to 438,183,527. The trading window for designated persons reopens on February 16, 2026.
The €15.3 million Europe-focused investment signals Ixigo's intent to pursue international expansion through acquisitions, which could be a growth catalyst but also carries execution risk. The ESOP allotment causes only negligible dilution (~0.026%) and is routine. Short-term stock impact is likely limited, though the European acquisition plans may attract investor attention.